This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greatbatch, Inc. Reports 2012 Second Quarter Results

Greatbatch, Inc. (NYSE: GB), today announced results for its second quarter ended June 29, 2012:

  • Sales increased 14% over the prior year to a record $166.5 million, and included the following:
    • $21.3 million of revenue contributed from the acquisition of Micro Power Electronics, Inc.;
    • 16% Vascular Access growth driven by commercialization of medical devices;
    • 3% increase in CRM/Neuromodulation revenue, ahead of our expectations;
    • 13% decline in Orthopaedics revenue (-5% constant currency) due to lower customer product launches, pricing pressures and poor execution at our Swiss facilities;
    • Organic constant currency growth of 1%.
  • Second quarter GAAP diluted EPS decreased 56% versus the prior year primarily due to higher consolidation and optimization activities. On an adjusted basis, diluted EPS was $0.43 per share, consistent with the prior year.
  • Similar to GAAP diluted EPS, GAAP operating income decreased 39% in comparison to the prior year. Adjusted operating income increased 1% over the prior year as higher gross profits were offset by increased RD&E investment in the development of medical devices.
  • Cash flows from operations were $24 million for the second quarter which enabled the Company to pay down an additional $8 million of long-term debt.
 
Three Months Ended
(Dollars in thousands, except per share data) June 29,   July 1,   %   March 30,   %
  2012   2011 Change   2012 Change
Sales $ 166,548 $ 146,524 14% $ 159,103 5%
 
GAAP Operating Income $ 11,091 $ 18,303 -39% $ 11,198 -1%
GAAP Operating Income as % of Sales 6.7% 12.5% 7.0%
 
Adjusted Operating Income* $ 18,589 $ 18,417 1% $ 15,515 20%
Adjusted Operating Income as % of Sales 11.2% 12.6% 9.8%
 
GAAP Diluted EPS $ 0.16 $ 0.36 -56% $ 0.19 -16%
Adjusted Diluted EPS* $ 0.43 $ 0.43 0% $ 0.37 16%
 
* Refer to Tables A and B at the end of this release for a reconciliation of GAAP to adjusted amounts.
 




1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,040.37 +29.69 0.16%
S&P 500 2,111.73 +4.34 0.21%
NASDAQ 5,082.9290 +12.9030 0.25%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs